Compare Wegovy injection and the Wegovy pill: dosing, routine, storage, STEP vs OASIS trial results, and MHRA UK licensing on 11 June 2026
In a Phase 2b study in people with type 2 diabetes and obesity over 54 weeks, treatment with cotadutide at doses of 100-300 g daily improved some non-invasive markers of NAFLD such as transaminase levels, the FIB-4 index, fatty liver disease fibrosis score (NFS) and fatty liver index (FLI) but fatty liver disease was not assessed directly with liver biopsy
Ro said it hopes its new tool can help patients understand their coverage options so they can decide how to pursue weight loss
No one benefits from weight bias. Another common criticism of the guidelines was that they could promote disordered eating in kids, NBC News reported
Weight loss was significant in outcome trials, ranging from a 0.6 kg reduction at 12 weeks in the ELIXA trial to a 4.3 kg reduction at 2 years with injectable semaglutide in the SUSTAIN-6 trial